WO1996017865A3 - Genes et produits geniques pour le diagnostic de lesions nerveuses degeneratives - Google Patents

Genes et produits geniques pour le diagnostic de lesions nerveuses degeneratives Download PDF

Info

Publication number
WO1996017865A3
WO1996017865A3 PCT/EP1995/004777 EP9504777W WO9617865A3 WO 1996017865 A3 WO1996017865 A3 WO 1996017865A3 EP 9504777 W EP9504777 W EP 9504777W WO 9617865 A3 WO9617865 A3 WO 9617865A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
gene products
diagnosis
nerve damage
degenerative nerve
Prior art date
Application number
PCT/EP1995/004777
Other languages
German (de)
English (en)
Other versions
WO1996017865A2 (fr
Inventor
Hans-Werner Mueller
Clemens Gillen
Marc Gleichmann
Original Assignee
Boehringer Mannheim Gmbh
Mueller Hans Werner
Clemens Gillen
Marc Gleichmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19502525A external-priority patent/DE19502525A1/de
Application filed by Boehringer Mannheim Gmbh, Mueller Hans Werner, Clemens Gillen, Marc Gleichmann filed Critical Boehringer Mannheim Gmbh
Priority to EP95941669A priority Critical patent/EP0796275A2/fr
Priority to AU43023/96A priority patent/AU693982B2/en
Priority to JP8517317A priority patent/JPH10511544A/ja
Publication of WO1996017865A2 publication Critical patent/WO1996017865A2/fr
Publication of WO1996017865A3 publication Critical patent/WO1996017865A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne de nouveaux gènes et produits géniques, exprimés dans des nerfs périphériques dégénératifs et/ou régénératifs, ainsi que leur application à des fins diagnostiques et/ou thérapeutiques. Les acides nucléiques mentionnés dans SEQ ID NO:1 à 30 s'hybrident avec les acides nucléiques de l'invention.
PCT/EP1995/004777 1994-12-05 1995-12-05 Genes et produits geniques pour le diagnostic de lesions nerveuses degeneratives WO1996017865A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP95941669A EP0796275A2 (fr) 1994-12-05 1995-12-05 Genes et produits geniques pour le diagnostic de lesions nerveuses degeneratives
AU43023/96A AU693982B2 (en) 1994-12-05 1995-12-05 Genes and gene products for use in the diagnosis of degenerative nerve damage
JP8517317A JPH10511544A (ja) 1994-12-05 1995-12-05 変性神経損傷の診断及び再生のための新規遺伝子及び遺伝子産物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4443159 1994-12-05
DEP4443159.7 1994-12-05
DE19502525A DE19502525A1 (de) 1994-12-05 1995-01-27 Neue Gene und Genprodukte zur Diagnostik und Regeneration degenerativer Nervenschädigungen
DE19502525.3 1995-01-27

Publications (2)

Publication Number Publication Date
WO1996017865A2 WO1996017865A2 (fr) 1996-06-13
WO1996017865A3 true WO1996017865A3 (fr) 1996-09-19

Family

ID=25942564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/004777 WO1996017865A2 (fr) 1994-12-05 1995-12-05 Genes et produits geniques pour le diagnostic de lesions nerveuses degeneratives

Country Status (5)

Country Link
EP (1) EP0796275A2 (fr)
JP (1) JPH10511544A (fr)
AU (1) AU693982B2 (fr)
CA (1) CA2206994A1 (fr)
WO (1) WO1996017865A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003569A1 (fr) * 1989-08-30 1991-03-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Neurotrophine-3, un nouveau facteur neurotrophique relatif a la croissance des nerfs et facteur neurotrophique derive du cerveau
WO1992020797A1 (fr) * 1991-05-20 1992-11-26 Case Western Reserve University Facteur neurotrophique, sa preparation et ses utilisations
WO1994021670A1 (fr) * 1993-03-15 1994-09-29 The Scripps Research Institute Recepteurs humains de serotonine, adn codant les recepteurs et utilisation de ces derniers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003569A1 (fr) * 1989-08-30 1991-03-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Neurotrophine-3, un nouveau facteur neurotrophique relatif a la croissance des nerfs et facteur neurotrophique derive du cerveau
WO1992020797A1 (fr) * 1991-05-20 1992-11-26 Case Western Reserve University Facteur neurotrophique, sa preparation et ses utilisations
WO1994021670A1 (fr) * 1993-03-15 1994-09-29 The Scripps Research Institute Recepteurs humains de serotonine, adn codant les recepteurs et utilisation de ces derniers

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
A.E.FEUCHTER ET AL.: "Strategy for detecting cellular transcripts promoted by human endogenous long terminal repeats : identific<tion of a novel gene (cdc4l) with homology to yeast CDC4", GENOMICS, vol. 13, pages 1237 - 46, XP000568626 *
DE LEON M ET AL: "IDENTIFICATION OF TRANSCRIPTIONALLY REGULATED GENES AFTER SCIATIC NERVE INJURY", JOURNAL OF NEUROSCIENCE RESEARCH, 29 (4). 1991. 437-448. *
FISCHER I. ET AL.: "Moelcular cloning of plasmolipin", THE JOURNAL OF BIOCHEMICAL CHEMISTRY, vol. 269, no. 40, pages 24912 - 24919 *
GILLEN C ET AL: "Differentially expressed genes after peripheral nerve injury", JOURNAL OF NEUROSCIENCE RESEARCH, 42 (2). 1995. 159-171., XP000568934 *
K.HAYASAKA ET AL.: "Mutation of the myelin Po gene in Charcot-Marie-Tooth neuropathy type 1B", HUMAN MOLECULAR GENETICS, vol. 2, no. 9, pages 1369 - 1372, XP000566482 *
N.H.LEE ET AL.: "Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growt factor treatment", PNAS, vol. 92, pages 8303 - 8307 *
RAUTENSRAUSS B. ET AL.: "Identification of a de novo insertional mutation in P0 in a patient with Dejerine-Sottas syndrome (DSS) phenotype", HUMAN MOLECULAR GENETICS, vol. 3, no. 9, pages 1701 - 1702, XP000266483 *

Also Published As

Publication number Publication date
AU693982B2 (en) 1998-07-09
CA2206994A1 (fr) 1996-06-13
JPH10511544A (ja) 1998-11-10
AU4302396A (en) 1996-06-26
EP0796275A2 (fr) 1997-09-24
WO1996017865A2 (fr) 1996-06-13

Similar Documents

Publication Publication Date Title
CA2177357A1 (fr) Macromolecules chimeres pna-dna-pna
CA2294516A1 (fr) Proteines ikk-.beta., acides nucleiques et procedes
EP1700915A3 (fr) Molécules d&#39;ADN enzymatiques
WO1998020165A3 (fr) Marqueurs bialleliques
CA2295999A1 (fr) Proteines nik, acides nucleiques et procedes correspondants
PL328563A1 (en) Oligonucleotides of modified sugar residues
EP0774518A3 (fr) Sondes d&#39;acides nucléiques complémentaires aux acides nucléiques du virus du Papillome humain, procédés associés et trousse d&#39;essais
EP1044987A3 (fr) Oligonucléotides modifiés en 2&#39; à ouverture
CA2174315A1 (fr) Modulation par les oligonucleotides de la proteine associee a la resistance multiples aux anticancereux
CA2194761A1 (fr) Oligonucleotides immunomodulateurs
DE69829287D1 (de) Verbesserung der verabreichung der nukleinsäure in zellen der plurizellulären eukaryotischen organismen und kombination zur durchführung des verfahrens
EP1439230A3 (fr) Gène de la protéine transmembranaire humaine TMP-2
CA2221448A1 (fr) Modulation par oligonucleotides antisens de l&#39;expression de genes raf
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d&#39;utilisation correspondants
WO1997003192A3 (fr) Gene du chromosome 1 et produits genetiques lies a la maladie d&#39;alzheimer
EP1715035A3 (fr) Polynucleotides synthetiques encodant lysyl oxidase
WO1998018932A3 (fr) Nouvelles toxines pesticides et sequences nucleotidiques codant pour celles-ci
AU2299999A (en) Dnas or genes participating in parkinson&#39;s disease
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d&#39;un seul nucleotide et utilisations de ces acides nucleiques
CA2304926A1 (fr) Robo : une famille de polypeptides et d&#39;acides nucleiques impliques dans le guidage des nerfs
WO1998054313A3 (fr) Sequences genomiques d&#39;adn methyltransferase et oligonucleotides antisens
EP1005539A4 (fr) PROTEINES IKK-$g(a), ACIDES NUCLEIQUES ET PROCEDES
AU5137498A (en) Iga nephropathy-associated gene
CA2146320A1 (fr) Inhibition de l&#39;oligonucleotide antisens du gene ras
CA2340934A1 (fr) Nouvelle collectine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1995941669

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2206994

Country of ref document: CA

Ref country code: CA

Ref document number: 2206994

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: US

Ref document number: 1997 849134

Date of ref document: 19970728

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1995941669

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1995941669

Country of ref document: EP